SUMMARY OF OUTSTANDING STOCK WARRANTS (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Equity [Abstract] | |||
| Number of Warrants Balance Beginning | 326,779 | 287,656 | |
| Weighted average exercise price, balance beginning | $ 25.54 | $ 12.64 | |
| Weighted average remaining contractual life, balance ending | 2 years 6 months | 3 years 6 months | 2 years 8 months 12 days |
| Number of Warrants Issued | 375,000 | ||
| Weighted average exercise price issued | $ 25.00 | ||
| Number of Warrants Expired | (2,404) | (19,792) | |
| Weighted average exercise price expired | $ 52.00 | $ 27.20 | |
| Number of Warrants Exercised | (316,085) | ||
| Weighted average exercise price exercised | $ 14.42 | ||
| Number of Warrants Exercised | 316,085 | ||
| Number of Warrants Balance Ending | 324,375 | 326,779 | 287,656 |
| Weighted average exercise price, balance ending | $ 25.00 | $ 25.54 | $ 12.64 |
| Number of warrants exercisable | 324,375 | ||
| Weighted average exercise price exercisable | $ 25.00 | ||
| Weighted average remaining contractual life, warrant exerciable balance ending | 2 years 6 months | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of equity instruments non equity options exercisable, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment non option equity instrument weighted average exercise price exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price Expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price issued. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, outstanding. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|